Doctors Note Logo

Published on: 8/18/2026

The Science of Ethanol Toxicity: Why Alcoholism Impairs Hepatic Vitamin D Hydroxylation

Chronic ethanol exposure disrupts the liver's first step of vitamin D activation, 25-hydroxylation, by depleting NAD+, flooding hepatocytes with acetaldehyde and oxidative stress, and downregulating the CYP2R1 and CYP27A1 enzymes that convert vitamin D into 25-hydroxyvitamin D. Alcoholism compounds this through poor dietary intake, fat malabsorption, reduced hepatic synthesis of vitamin D binding protein, and induction of CYP24A1, the enzyme that degrades vitamin D metabolites, which together drive low 25(OH)D levels, secondary hyperparathyroidism, bone loss, muscle weakness, and impaired immunity. The degree of impairment varies with the stage of liver injury, from steatosis to fibrosis and cirrhosis, so several important factors deserve attention, and the details are explained below.

If you are noticing fatigue, bone or muscle aches, frequent infections, or other symptoms that may point to vitamin D deficiency or liver strain, a free, instant, online symptom check can help you organize what you are experiencing in just a few minutes. It is a private, no-cost way to understand which possibilities fit your situation and what type of care or testing to pursue next, so you can walk into an app

answer background

Explanation

The Science of Ethanol Toxicity: Why Alcoholism Impairs Hepatic Vitamin D Hydroxylation

Chronic alcohol use disorder (AUD) is more than just a social or psychological issue—it has profound effects on many organs, especially the liver. One under‐recognized consequence is impaired vitamin D metabolism, which can lead to osteomalacia in chronic alcohol use disorder. This article explores how ethanol toxicity disrupts hepatic vitamin D hydroxylation, why this matters for bone health, and what steps can help mitigate risk.


1. Ethanol Metabolism and Liver Injury

When you consume alcohol, your liver works hard to break it down. Key pathways include:

  • Alcohol dehydrogenase (ADH)
    Converts ethanol to acetaldehyde, a toxic intermediate.
  • Aldehyde dehydrogenase (ALDH)
    Converts acetaldehyde into acetate.
  • Cytochrome P450 2E1 (CYP2E1)
    An inducible system that becomes more active with chronic drinking, generating reactive oxygen species (ROS) and free radicals.

Why this matters:
• Acetaldehyde and ROS damage liver cells (hepatocytes).
• Chronic injury triggers inflammation and fibrosis.
• As liver tissue is lost or scarred, its ability to perform normal functions—including vitamin D hydroxylation—declines.


2. Hepatic Vitamin D Hydroxylation: The Critical First Step

Vitamin D obtained from sunlight (as D3) or diet (D2/D3) must be “activated.” The first activation step occurs in the liver:

  • Enzyme: 25-hydroxylase (mainly CYP2R1)
    Converts vitamin D into 25-hydroxyvitamin D [25(OH)D], the major circulating form.
  • Location: Hepatocyte mitochondria and endoplasmic reticulum

Impact of ethanol toxicity:

  • Reduced enzyme expression
    Studies show chronic ethanol downregulates CYP2R1 mRNA and protein.
  • Mitochondrial dysfunction
    ROS damage mitochondrial membranes, impairing enzyme activity.
  • Malnutrition and malabsorption
    Many people with AUD have poor dietary intake, gastrointestinal mucosal damage, and fat‐soluble vitamin malabsorption—all of which lower substrate availability for 25-hydroxylation.

3. Downstream Effects on Vitamin D Status

When the liver can’t efficiently produce 25(OH)D:

  1. 25(OH)D levels drop
    Clinical labs often find values below the normal range (<20 ng/mL).
  2. Reduced 1,25-dihydroxyvitamin D [1,25(OH)₂D] formation
    The kidney’s second hydroxylation step depends on adequate 25(OH)D.
  3. Calcium and phosphate imbalance
    Low active vitamin D leads to:
    • Poor intestinal absorption of calcium and phosphate
    • Secondary hyperparathyroidism (to maintain blood calcium)
    • Increased bone resorption (bone breakdown)

4. From Impaired Hydroxylation to Osteomalacia

Osteomalacia is a softening of bones due to defective mineralization of the osteoid matrix. In chronic alcohol use disorder:

  • Pathophysiology
    • Inadequate mineral deposition in bone
    • Accumulation of unmineralized osteoid
  • Contributing factors
    • Low vitamin D metabolites
    • Hypocalcemia (low blood calcium)
    • Hypophosphatemia (low blood phosphate)
    • Nutritional deficiencies (protein, magnesium)
  • Clinical features
    • Diffuse bone pain and tenderness
    • Muscle weakness or waddling gait
    • Increased risk of insufficiency fractures (rib, pelvis, femur)

Epidemiological data indicate a higher prevalence of osteomalacia and low bone mineral density in populations with heavy, chronic alcohol use.


5. Recognizing Symptoms Early

Symptoms of vitamin D deficiency and early osteomalacia can be subtle:

  • Generalized fatigue
  • Mild diffuse aches in hips, lower back, or legs
  • Difficulty climbing stairs or rising from a chair
  • Occasional bone fractures with minimal trauma

If you or someone you know has these signs—especially against a background of heavy alcohol use—consider a free, online symptom check, using the doctor approved Ubie Symptom Checker (https://ubiehealth.com/) to help clarify next steps.


6. Prevention and Management Strategies

  1. Alcohol reduction or cessation
    • Slows progression of liver injury
    • Improves nutritional status
  2. Nutritional optimization
    • Adequate calories, protein, and micronutrients
    • Emphasize foods rich in vitamin D (fatty fish, fortified dairy)
  3. Vitamin D supplementation
    • Doses guided by serum 25(OH)D levels
    • Typical regimens range from 800 to 2,000 IU daily, higher if deficient
  4. Calcium and phosphate correction
    • May require oral calcium carbonate or calcium citrate
    • Phosphate supplements if levels are low
  5. Monitoring and follow-up
    • Serum 25(OH)D, calcium, phosphate, alkaline phosphatase
    • Bone mineral density (DEXA scan) for at-risk individuals
  6. Multidisciplinary support
    • Hepatology or gastroenterology consult for liver care
    • Endocrinology for severe vitamin D or bone issues
    • Addiction specialists for alcohol use disorder

7. When to Speak to Your Doctor

Some symptoms or signs can signal more serious problems:

  • Sudden severe abdominal pain or distension
  • Leg swelling or jaundice (yellowing of skin/eyes)
  • Confusion, severe fatigue, or signs of hepatic encephalopathy
  • Signs of fracture or intense bone pain

If you experience any of these, speak to a doctor as soon as possible. Early intervention can be life‐saving.


Key Takeaways

  • Chronic alcohol use injures the liver, impairing the 25-hydroxylation of vitamin D.
  • Low 25(OH)D levels lead to poor bone mineralization and osteomalacia in chronic alcohol use disorder.
  • Early symptoms are mild but progress to painful, debilitating bone disease if untreated.
  • Strategies include alcohol cessation, nutritional support, targeted supplementation, and medical monitoring.
  • Consider a free, online symptom check, using the doctor approved Ubie Symptom Checker (https://ubiehealth.com/) to guide your next steps, but always follow up with a healthcare professional for any serious concerns.

Being proactive about liver health and vitamin D status can make a significant difference in preventing osteomalacia and maintaining overall well‐being. If you have any worrying symptoms or a history of heavy drinking, don’t hesitate to seek medical advice.

(References)

  • * Ziegler R. [Osteoporosis]. Schweiz Rundsch Med Prax. 1994 Sep 20;83(38):1051-5. PMID: 7939067.

  • * Bikle DD. Alcohol-induced bone disease. World Rev Nutr Diet. 1993;73:53-79. doi: 10.1159/000422460. PMID: 8367983.

  • * Imanishi Y, Inaba M. [Secondary hyperparathyroidism]. Nihon Rinsho. 2006 Jun 28;Suppl 2:31-6. PMID: 16817344.

  • * Felsenfeld AJ, Levine BS. Approach to treatment of hypophosphatemia. Am J Kidney Dis. 2012 Oct;60(4):655-61. doi: 10.1053/j.ajkd.2012.03.024. Epub 2012 Aug 3. PMID: 22863286.

  • * Kumar N. Nutrients and Neurology. Continuum (Minneap Minn). 2017 Jun;23(3, Neurology of Systemic Disease):822-861. doi: 10.1212/01.CON.0000520630.69195.90. PMID: 28570331.

  • * Kanda N, Hoashi T, Saeki H. Nutrition and Psoriasis. Int J Mol Sci. 2020 Jul 29;21(15). doi: 10.3390/ijms21155405. Epub 2020 Jul 29. PMID: 32751360; PMCID: PMC7432353.

  • * Farrah Z, Jawad AS. Optimising the management of osteoporosis. Clin Med (Lond). 2020 Sep;20(5):e196-e201. doi: 10.7861/clinmed.2020-0131. PMID: 32934064; PMCID: PMC7539745.

  • * Ito N, Hidaka N, Kato H. The pathophysiology of hypophosphatemia. Best Pract Res Clin Endocrinol Metab. 2024 Mar;38(2):101851. doi: 10.1016/j.beem.2023.101851. Epub 2023 Nov 30. PMID: 38087658.

  • * Gao X, Min Y, Lin R, Liang D, Zhang M, Xiao Q, Lu Y, Zhang F, Xu B, Liu Y. Vitamin D Alleviates Osteoarthritis Progression by Targeting Cartilage and Subchondral Bone via Myd88-TAK1-ERK Axis Suppression. Drug Des Devel Ther. 2025;19:5855-5870. doi: 10.2147/DDDT.S526064. Epub 2025 Jul 8. PMID: 40657039; PMCID: PMC12255330.

  • * Santucci C, Natale A, Pelucchi C, Bonzi R, Lunet N, Morais S, Vioque J, González-Palacios S, Aragonés N, Castaño-Vinyals G, Malekzadeh R, Pakseresht M, Negri E, Boffetta P, Camargo MC, Curado MP, Zhang ZF, Boccia S, La Vecchia C, Rossi M. Dietary vitamin D and gastric cancer risk within the stomach cancer pooling (stop) project. Eur J Nutr. 2025 Aug 31;64(6):269. doi: 10.1007/s00394-025-03768-w. Epub 2025 Aug 31. PMID: 40886187; PMCID: PMC12399693.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.